Table 2 Demographic findings and results.

From: Left ventricular active strain energy density is a promising new measure of systolic function

Results

Normal

Hypertension

Dilated cardiomyopathy

Amyloid

Number (M/F)

39 (21/18)

55 (32/23)

53 (37/16)

36 (32/4)

Age (years)

45 ± 14

52 ± 13*

54 ± 16*

70 ± 10***†††‡‡‡

BMI (kg/m2)

25.7 ± 4.7

30.5 ± 4.3***

28.5 ± 6.2

25.6 ± 3.7†††

Weight (kg)

75.2 ± 14.6

90.4 ± 15.5***

85.6 ± 20.9*

76.6 ± 14.8††

BSA (m2)

1.88 ± 0.21

2.07 ± 0.22**

2.02 ± 0.27*

1.91 ± 0.21††

Systolic BP (mmHg)

125 ± 12

174 ± 29***

116 ± 16†††

133 ± 29†††‡‡

Diastolic BP (mmHg)

76.3 ± 9.1

99 ± 16***

68 ± 14**†††

83 ± 10*†††‡‡‡

LVEDV (mL)

146 ± 40.0

177 ± 34.2*

267 ± 59.2***†††

164 ± 67.0‡‡‡

LVESV (mL)

55.4 ± 21.4

61.2 ± 21.5

189 ± 63.6***†††

89.7 ± 60.0**†‡‡‡

Stroke volume (mL)

90.6 ± 23.7

115.0 ± 23.4***

76.9 ± 27.5*†††

74.4 ± 22.6*†††

SV/BSA (mL/m2)

48.1 ± 11.9

55.5 ± 9.7*

38.5 ± 12.8**†††

41.3 ± 18.4†††

SV/Height2.7 (mL/m2.7)

52.7 ± 12.5

66.9 ± 13.7***

44.0 ± 15.0*†††

43.0 ± 12.5*†††

LV muscle mass (g)

109 ± 29

200 ± 55***

187 ± 48***

215 ± 78***

LVIDd (mm)

52 ± 5.1

51 ± 4.5

67 ± 5.0***†††

52 ± 7.4‡‡‡

LVIDs (mm)

35.1 ± 4.6

31.6 ± 5.9

59.4 ± 5.9***†††

40.6 ± 9.7**†††‡‡‡

EDWT (mm)

7.6 ± 1.2

10.5 ± 2.5***

7.9 ± 1†††

14.1 ± 2.7***†††‡‡‡

ESWT (mm)

12.0 ± 1.6

16.8 ± 3.4***

10.1 ± 1.8**†††

17.9 ± 2.8***‡‡‡

LV length (mm)

96.7 ± 8.5

99.8 ± 8.0

105 ± 7.9***††

98.5 ± 8.3‡‡

EF (%)

63.8 ± 6.6

66.0 ± 8.4

29.6 ± 11.2***†††

49 ± 15.5***†††‡‡‡

EFc (%)

64.8 ± 5.6

59.0 ± 8.8**

35.2 ± 7.6***†††

39.6 ± 9.2***†††

Myocardial Contr. Frac. (%)

89.9 ± 16.5

63.9 ± 15.4***

45.8 ± 17.6***†††

40.8 ± 18.2***†††

Long. shortening (%)

15.5 ± 2.5

10.8 ± 2.6***

5.8 ± 2.9***†††

6.1 ± 2.6***†††

Circ. shortening (%)

18.4 ± 2.2

17.3 ± 3.3

7.8 ± 3.1***†††

9.3 ± 3.4***†††

Radial thickening (%)

61.3 ± 14.6

61.8 ± 14.4

29.9 ± 10.2***†††

30.8 ± 13.4***†††

Lamé Long. σ SBP (KPa)

25.1 ± 4.8

25.1 ± 8.5

30.2 ± 6.4*††

13.5 ± 4.9***†††‡‡‡

Lamé Long. σ MAP (KPa)

18.6 ± 3.8

17.8 ± 5.8

21.7 ± 4.7*†††

10.1 ± 4.7***†††‡‡‡

Lamé Long. σ DBP (KPa)

15.4 ± 3.3

14.2 ± 4.7

17.6 ± 3.9††

8.5 ± 3.2***†††‡‡‡

Laplace Long. σ SBP (KPa)

28.7 ± 4.9

29.9 ± 9.1**

33.6 ± 6.5***

17.0 ± 5.2†††‡‡‡

Lamé Circ. σ SBP (KPa)

57.0 ± 9.9

58.8 ± 18.3

66.8 ± 13.0**

33.1 ± 10.5***†††‡‡‡

Laplace Circ. σ SBP (KPa)

57.5 ± 9.9

59.8 ± 18.2

67.2 ± 12.9**

34.0 ± 10.5***†††‡‡‡

Cardiomyocyte σ (KPa)

34.6 ± 7.3

31.9 ± 10.4

39.4 ± 8.6†††

19.3 ± 7.2***†††‡‡‡

Peak TIN force (N)

203 ± 51.2

286 ± 81.1***

385 ± 74.9***†††

257 ± 107*‡‡‡

Peak Long. force (N)

26.0 ± 6.2

33.5 ± 9.5***

49.2 ± 8.0***†††

32.2 ± 13.0*‡‡‡

Peak TIN force/LVM (N/g)

1.89 ± 0.31

1.50 ± 0.48***

2.14 ± 0.44*†††

1.28 ± 0.47***‡‡‡

Peak Long. force/LVM (N/g)

0.24 ± 0.05

0.18 ± 0.07***

0.27 ± 0.06†††

0.16 ± 0.06***‡‡‡

Stroke work (J)

1.12 ± 0.32

1.88 ± 0.43***

0.86 ± 0.30**†††

0.98 ± 0.32†††

Stroke work/LVM (J/Kg)

10.4 ± 2.3

9.9 ± 2.7

4.8 ± 1.8***†††

5.1 ± 2.4***†††

Stroke work/H2.7 (J/m2.7)

0.262 ± 0.076

0.439 ± 0.103***

0.192 ± 0.066***†††

0.225 ± 0.071†††

Pressure-strain loop (mHg%)

1.93 ± 0.36

1.86 ± 0.47

0.67 ± 0.34***†††

0.81 ± 0.37***†††

GLASED MAP (KJ/m3))

1.44 ± 0.37

0.988 ± 0.454***

0.618 ± 0.32***†††

0.312 ± 0.19***†††‡‡‡

GLASED SBP (KJ/m3)

1.94 ± 0.49

1.39 ± 0.65***

0.86 ± 0.45***†††

0.42 ± 0.28***†††‡‡‡

Laplace SSP SBP (KJ/m3)

2.14 ± 0.55

1.67 ± 0.74**

0.99 ± 0.45***†††

0.58 ± 0.36***†††‡

Laplace SSP MAP (KJ/m3)

1.58 ± 0.42

1.18 ± 0.52***

0.710 ± 0.38***†††

0.432 ± 0.25***†††‡‡‡

GLASE SBP (J)

0.199 ± 0.073

0.240 ± 0.082*

0.146 ± 0.080**†††

0.077 ± 0.043***†††‡‡‡

GLASE MAP (J)

0.147 ± 0.055

0.17 ± 0.056

0.105 ± 0.057***†††

0.057 ± 0.03***†††‡‡‡

GLASE SBP/BSA (cJ/m2)

10.60 ± 3.78

11.76 ± 4.37

7.20 ± 3.59***†††

4.09 ± 2.55***†††‡‡‡

GLASE SBP/H2.7 (cJ/m2.7)

4.65 ± 1.55

5.70 ± 2.31*

3.23 ± 1.59*†††

1.77 ± 1.06***†††‡‡‡

CASED SBP (KJ/m3)

5.26 ± 1.24

5.20 ± 2.08

2.60 ± 1.13***†††

1.56 ± 0.78***†††‡‡

CASE SBP (J)

0.535 ± 0.175

0.917 ± 0.306***

0.450 ± 0.203†††

0.287 ± 0.119***†††‡‡

CASE SBP/H2.7 (J/m2.7)

0.125 ± 0.037

0.217 ± 0.083***

0.101 ± 0.043*†††

0.066 ± 0.028***†††‡‡

  1. Values expressed as mean ± 1 standard deviation.
  2. Long. Longitudinal, Circ. midwall circumferential, EDWT end-diastolic wall thickness, ESWT end-systolic wall thickness, LVIDd LV internal diastolic diameter, SV stroke volume, LVIDs LV internal systolic diameter, BSA body surface area, TIN total inward net force, LVM LV muscle mass, EFc corrected ejection fraction (5 factor)17, Myocardial Contr. Frac. Myocardial contraction fraction, SBP systolic blood pressure, MAP mean arterial blood pressure, σ stress, DBP diastolic blood pressure, Lapl. Laplace, SSP stress–strain product, H height.
  3. *P < 0.05, **P < 0.001, ***P < 0.0001 cf. control.
  4. Dilated cardiomyopathy or Amyloid vs Hypertension.
  5. Amyloid vs dilated cardiomyopathy. All other comparisons not significant (P > 0.05).